Depression is due to the increased production of pro-inflammatory cytokines by microglia activation, and fluoxetine can attenuate LPS-induced production of IL-1β and p-NF-κB expression in microglia (Yang et al., 2014). Here, IL1B is linked to depressive symptom measurement.